{
    "clinical_study": {
        "@rank": "13179", 
        "arm_group": {
            "arm_group_label": "Intervention", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The use of Impella RP is safe, feasible and provides a hemodynamic benefit in patients with\n      right ventricular failure."
        }, 
        "brief_title": "The Use of Impella RP Support System in Patients With Right Heart Failure", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Right Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients that have developed signs of right ventricular failure either: A) within 48\n             hours post-implantation of an FDA approved implantable surgical LVAD (left\n             ventricular assist device )(Cohort A) or B) subsequent to postcardiotomy shock within\n             48 hours post surgery or post myocardial infarction (Cohort B).\n\n          2. Age \u226518 years old\n\n          3. Signed Informed consent\n\n        Exclusion Criteria\n\n          1. INTERMACS 1 patients (Critical cardiogenic shock patient who is \"crashing and\n             burning\", has life-threatening hypotension and rapidly escalating inotropic or\n             pressor support, with critical organ hypoperfusion often confirmed by worsening\n             acidosis and lactate levels)\n\n          2. Evidence of acute neurologic injury\n\n          3. RA(right atrium),RV (right Ventricle) and/or  PA (pulmonary artery) thrombus\n\n          4. Intolerance to anticoagulant or antiplatelet therapies\n\n          5. Existing congenital heart disease that would preclude the insertion of the device.\n\n          6. Participation in any other clinical investigation that is likely to confound study\n             results or affect study outcome\n\n          7. Acute Myocardial Infarction (AMI) with mechanical complications ( ventricular septal\n             defect, myocardial rupture, papillary muscle rupture)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01777607", 
            "org_study_id": "Recover Right"
        }, 
        "intervention": {
            "arm_group_label": "Intervention", 
            "intervention_name": "IMPELLA\u00ae RP", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 11, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mfox2@hfhs.org", 
                    "last_name": "Margaret Fox, RN", 
                    "phone": "313-916-1879"
                }, 
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Henry Ford Hospital"
                }, 
                "investigator": {
                    "last_name": "William O'Neill, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "FlynnMag@einstein.edu", 
                    "last_name": "Maggie Flynn", 
                    "phone": "267-421-7439"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19141"
                    }, 
                    "name": "Albert Einstein Medical Center"
                }, 
                "investigator": {
                    "last_name": "Mark Anderson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Use of Impella RP Support System in Patients With Right Heart Failure: A Clinical and Probable Benefit Study", 
        "overall_official": [
            {
                "affiliation": "Henry Ford Hospital", 
                "last_name": "William O.Neill, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Albert Einstein Medical Center", 
                "last_name": "Mark Anderson, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Survival at 30 days or hospital discharge whichever is longer post device explant or to the next therapy, including transplant, bridge to transplant or destination therapy with FDA approved surgical VAD (Ventricular Assit Device).", 
            "measure": "Primary Benefit Endpoint", 
            "safety_issue": "No", 
            "time_frame": "30 Days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01777607"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Abiomed Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abiomed Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}